Skip to main content

TELA Bio, Inc 10-Q for FY2026 Q3

TELA Bio, Inc. (TELA)

10-Q 2026-11-10 For: 2026-09-30
View Original
Added on November 10, 2026

About this 10-Q

TELA Bio, Inc filed this 10-Q on November 10, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

TELA Bio's quarterly revenue fell 8% to $19.0 million and net loss rose 8% to $9.3 million. It implemented cost actions targeting approximately $17.0 million in annual operating-expense reductions through a targeted headcount reduction of approximately 20%. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$18.96M
down 8.4% from $20.69M a year earlier
Net loss
$9.3M
compared with a net loss of $8.6M a year earlier
Diluted EPS
-$0.16
compared with -$0.19 a year earlier